Looking back at biotech history and when twiggy backed Admedus (asx:AHZ) it went from less than 2c to over 18c in late 2013. AHZ had a similar amount of shares on issue at the time to SBN, so market cap would've been over $200m. Not saying the same is gonna happen here but sometimes it's worth backing the jockey not the horse.
